Week 1 HW: Principles and Practices
HTGAA Week 1 – Class Assignment Student: Camarena Trujillo, Leonardo Joaquín
1. Biological engineering application
I would like to work on a portable, non-invasive glucose monitoring biosensor based on enzymatic detection. The idea is to use enzymes such as glucose oxidase to detect glucose levels from alternative body fluids like sweat or saliva, instead of traditional finger-prick blood tests.
Conventional glucose monitoring can be painful and inconvenient, especially for patients who need to test multiple times a day. Because of this, many people do not monitor their glucose regularly. A non-invasive and affordable device could make monitoring easier and more frequent, helping prevent long-term complications.
As a biomedical engineering student, I am interested in technologies that improve daily life for patients with chronic diseases. Diabetes is very common in many countries, including Peru, and access to continuous monitoring devices is still limited. A portable enzymatic biosensor could help improve adherence to treatment and overall quality of life.
2. Governance and policy goals
The main goal is to ensure that this technology is safe, reliable, and accessible, while also protecting patient data.
Sub-goals
- Protect patient data and privacy
- Ensure clinical accuracy and safety
- Promote equitable access
3. Governance actions
Option 1: Clinical validation before commercialization
Purpose:
Require proper clinical testing before the device enters the market.
Design:
- Approval by national health authorities
- Mandatory clinical trials
Assumptions:
- Regulators have enough resources
- Trials reflect real-world conditions
Risks:
- Higher development costs
- Slower innovation
Option 2: Strong data protection and user control
Purpose:
Protect sensitive health data collected by the biosensor.
Design:
- Encrypted data transmission
- Clear consent for data sharing
- User ownership of personal data
Assumptions:
- Companies comply with regulations
- Users understand consent options
Risks:
- Increased system complexity
- Higher development costs
Option 3: Public health subsidies for access
Purpose:
Make the biosensor accessible to more patients.
Design:
- Government or insurance subsidies
- Integration into public healthcare programs
Assumptions:
- Sufficient funding is available
- Distribution systems are effective
Risks:
- Budget limitations
- Unequal access in remote areas
4. Scoring governance options
| Policy Goal | Option 1 | Option 2 | Option 3 |
|---|---|---|---|
| Prevent incidents | 1 | 2 | 2 |
| Help respond to incidents | 2 | 2 | 1 |
| Device safety | 1 | 2 | 2 |
| Environmental protection | 2 | 2 | 2 |
| Minimize costs | 3 | 2 | 1 |
| Feasibility | 2 | 2 | 2 |
| Not impede research | 2 | 2 | 1 |
| Promote constructive use | 2 | 1 | 1 |
5. Recommended strategy
I would prioritize a combination of Option 2 and Option 3.
Protecting patient data is essential, especially in continuous monitoring devices. At the same time, these technologies should be accessible to patients from different socioeconomic backgrounds. Public health programs and subsidies could help ensure broader access.
Option 1 is also important, but regulations should be balanced so they do not unnecessarily slow down innovation.
6. Ethical reflection
One important ethical concern is the handling of sensitive health data. Continuous monitoring systems generate large amounts of personal medical information, which could be misused if not properly protected.
Another issue is inequality. If non-invasive biosensors remain expensive, only certain populations will benefit from them, which could increase health disparities.
Possible governance actions:
- Strong data protection policies
- Transparent consent mechanisms
- Subsidies for low-income patients
- Integration into public healthcare systems